Reuters

Johnson & Johnson’s blood cancer therapy gets US FDA approval

Read more

Pfizer COVID vaccine price hike seen giving revenue boost for years

Read more

Three pharma companies recall products in US

Read more

Indonesia considers prosecutions over cough syrup suspected of links to child deaths

Read more

AstraZeneca drug fails one main goal in study of chronic immune disease

Read more

Novartis to uphold generic drug supply despite surging energy costs

Read more

Biogen raises annual profit forecast for second straight quarter

Read more

US FDA authorises Novavax’s COVID vaccine as booster for adults

Read more

EMA recommends Moderna’s updated Omicron-tailored vaccine

Read more

Merck under formal investigation in France over thyroid drug

Read more